Canopy Growth Corporation (CGC): Price and Financial Metrics

Canopy Growth Corporation (CGC): $5.59

-0.30 (-5.09%)

POWR Rating

Component Grades














  • Growth is the dimension where CGC ranks best; there it ranks ahead of 73.07% of US stocks.
  • CGC's strongest trending metric is Growth; it's been moving up over the last 179 days.
  • CGC ranks lowest in Momentum; there it ranks in the 0th percentile.

CGC Stock Summary

  • With a year-over-year growth in debt of 142.67%, Canopy Growth Corp's debt growth rate surpasses 92.58% of about US stocks.
  • The volatility of Canopy Growth Corp's share price is greater than that of 92.56% US stocks with at least 200 days of trading history.
  • Canopy Growth Corp's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -30.03%, greater than the shareholder yield of only 13.28% of stocks in our set.
  • Stocks that are quantitatively similar to CGC, based on their financial statements, market capitalization, and price volatility, are FRGI, HCCI, TSC, RUTH, and CSSE.
  • Visit CGC's SEC page to see the company's official filings. To visit the company's web site, go to

CGC Price Target

For more insight on analysts targets of CGC, see our CGC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $23.58 Average Broker Recommendation 2 (Hold)

CGC Stock Price Chart Interactive Chart >

Price chart for CGC

CGC Price/Volume Stats

Current price $5.59 52-week high $26.96
Prev. close $5.89 52-week low $4.82
Day low $5.56 Volume 3,909,600
Day high $5.95 Avg. volume 7,370,218
50-day MA $6.45 Dividend yield N/A
200-day MA $10.54 Market Cap 2.20B

Canopy Growth Corporation (CGC) Company Bio

Canopy Growth Corporation is a diversified cannabis and cannabinoid-based consumer product company, offering customers a variety of options in dried flower oil, softgel capsule, infused beverage, edible, and topic formats. Spectrum Therapeutics is the company’s global medical brand, offering a full range of products. Canopy Growth markets products in the United States, Canada, Japan, and throughout Europe and has established relationships with companies such as BioSteel Sports Nutrition and Constellation Brands. The company is headquartered in Smith Falls, Canada and has a workforce of approximately 3,000 employees. Canopy Growth was founded in 2013 and David Klein has served as the company’s Chief Executive Officer since 2020.

CGC Latest News Stream

Event/Time News Detail
Loading, please wait...

CGC Latest Social Stream

Loading social stream, please wait...

View Full CGC Social Stream

Latest CGC News From Around the Web

Below are the latest news stories about Canopy Growth Corp that investors may wish to consider to help them evaluate CGC as an investment opportunity.

10 Stocks to Watch as They Hit Consumers With Higher Prices

America's top consumer brands are are facing higher input costs.

Will Ashworth on InvestorPlace | February 24, 2022

Are Any Marijuana Stocks On U.S. Exchanges Buys After Canopy, Aurora Earnings?

Are any Canadian marijuana stocks buys now, after Canopy Growth and Aurora Cannabis reported earnings?

Yahoo | February 23, 2022

Any Reason To Buy Canopy Growth After Signs Of Institutional Buying?

Canopy Growth has struggled. But some IBD data has signaled more institutional support. So is there any reason to buy CGC stock now?

Yahoo | February 23, 2022

This Is The Hidden Upside Driver For Canopy Growth''s Stock, According To A Leading Analyst

Since the beginning of the year, Canopy Growth (NASDAQ: CGC ) shares have dropped from 14.03% to $8.00 per share. The company began 2022 with the issuance of its Environmental, Social and Governance (ESG) report for the calendar year 2020, describing Canopy''s commitment to sustainability practices. It continued with two recent product launches – Martha Stewart CBD Wellness Topicals in collaboration with Martha Stewart and enhancement of the Tweed brand . About two weeks ago, the Ontario-based cannabis giant

Benzinga | February 18, 2022

Tilray’ Downtrend Should Soon Come to an End

The downward trend on TLRY stock might soon come to an end, amid an encouraging financial picture and increasing rumors that the cannabis legislation is close to a loosening in its core markets.

Cristian Docan on InvestorPlace | February 17, 2022

Read More 'CGC' Stories Here

CGC Price Returns

1-mo -5.73%
3-mo -27.40%
6-mo -54.11%
1-year -75.50%
3-year -87.08%
5-year -7.14%
YTD -35.97%
2021 -64.57%
2020 16.83%
2019 -21.51%
2018 13.58%
2017 246.87%

Continue Researching CGC

Here are a few links from around the web to help you further your research on Canopy Growth Corp's stock as an investment opportunity:

Canopy Growth Corp (CGC) Stock Price | Nasdaq
Canopy Growth Corp (CGC) Stock Quote, History and News - Yahoo Finance
Canopy Growth Corp (CGC) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.556 seconds.